DIUL GROUP 17 January 2017
Diurnal Group plc
('Diurnal' or the 'Company')
Director Dealings
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, received notification of the following purchase of shares by a person closely associated to a Company Director on 16 January 2017:
Mrs Lynne Raymond, wife of Alan Raymond, Non-executive Director, purchased 9,000 ordinary shares of 5.0 pence each in the Company ('Ordinary Shares') at a price of 110 pence per Ordinary Share. Following the transaction, Alan Raymond and his connected parties have a total interest of 22,888 Ordinary Shares, representing 0.04% of the total voting rights.
For further information, please visitwww.diurnal.co.uk or contact: | |
Diurnal Group plc | +44 (0)20 3727 1000 |
Martin Whitaker, CEO | |
Richard Bungay, CFO | |
Numis Securities Ltd (Nominated Adviser) | +44 (0)20 7260 1000 |
Nominated Adviser: Michael Meade, Freddie Barnfield, Paul Gillam | |
Corporate Broking: James Black | |
FTI Consulting | +44 (0)20 3727 1000 |
Simon Conway | |
Victoria Foster Mitchell | |
Notes to Editors
About Diurnal Group plc
Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
For further information about Diurnal, please visitwww.diurnal.co.uk
DEALING NOTIFICATION FORM FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
Details of the person discharging managerial responsibilities/person closely associated | ||||||
a) | Name: | Lynne Ryamond | ||||
Reason for the notification | ||||||
a) | Position/status: | Closely associated person to a Non-Executive Director | ||||
b) | Initial notification/Amendment: | Initial | ||||
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||
a) | Name: | Diurnal Group plc | ||||
b) | LEI: | n/a | ||||
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||
a) | Description of the financial instrument, type of instrument: Identification code: | Ordinary shares of 5p each. GB00BDB6Q760 | ||||
b) | Nature of the transaction: | Purchase | ||||
c) | Price(s) and volume(s): |
| ||||
d) | Aggregated information: | Aggregated volume: 9,000 Price: £9,900.00 | ||||
e) | Date of the transaction: | 16 January 2017 | ||||
f) | Place of the transaction: | XLON | ||||
Diurnal Group plc published this content on 17 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 February 2017 11:18:10 UTC.
Original documenthttp://otp.investis.com/clients/uk/diurnal_limited/rns/regulatory-story.aspx?cid=1282&newsid=837707
Public permalinkhttp://www.publicnow.com/view/6F7441F8FF03B830218B98DC1F5252F4EB7D4655
